Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate

Author:

Sundbaum Johanna Karlsson12ORCID,Baecklund Eva1,Eriksson Niclas34ORCID,Kohnke Hugo4,Wallenberg Matilda45,Cavalli Marco6ORCID,Wadelius Claes6ORCID,Wadelius Mia4ORCID,Hallberg Pär4ORCID

Affiliation:

1. Department of Medical Sciences, Rheumatology, Uppsala University, SE-751 85, Uppsala, Sweden

2. Department of Health Sciences, Luleå University of Technology, SE-971 87, Luleå, Sweden

3. Uppsala Clinical Research center, SE-751 85, Uppsala, Sweden

4. Department of Medical Sciences, Clinical Pharmacogenomics & Science for Life Laboratory, Uppsala University, SE-751 85, Uppsala, Sweden

5. Svensk Dos AB, Box 2, SE-751 03, Uppsala, Sweden

6. Department of Immunology, Genetics & Pathology, & Science for Life Laboratory, Uppsala University, SE-751 22, Uppsala, Sweden

Abstract

Aim: To identify novel genetic variants predisposing to elevation of Alanine aminotransferase (ALT) in rheumatoid arthritis (RA) patients after initiation of methotrexate (MTX) treatment. Patients & methods: We performed genome-wide association studies in 198 RA patients starting MTX. Outcomes were maximum level of ALT and ALT >1.5-times the upper level of normal within the first 6 months of treatment. Results: RAVER2 (rs72675408) was significantly associated with maximum level of ALT (p = 4.36 × 10-8). This variant is in linkage disequilibrium with rs72675451, which is associated with differential expression of JAK1 and RAVER2. Conclusion: We found an association between ALT elevation and genetic variants that may regulate the expression of JAK1 and RAVER2. JAK1 encodes a janus kinase involved in the pathogenesis of RA.

Funder

Reumatikerförbundet

Hjärt-Lungfonden

Diabetesförbundet

Avtal om Läkarutbildning och Forskning, Uppsala Universitet

Vetenskapsrådet

Agnes and Mac Rudberg's, Brunnberg's, Selander's and Thuréus' Foundations at Uppsala University

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3